Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis

BACKGROUND: Interstitial pneumonia (IP) is one of the most common and poor prognostic comorbidities in patients with small cell lung cancer (SCLC). The pharmacotherapy for SCLC occasionally induces fatal acute exacerbation of comorbid IP, especially in patients with idiopathic pulmonary fibrosis (IP...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Ther Adv Med Oncol
मुख्य लेखकों: Ikeda, Satoshi, Ogura, Takashi, Kato, Terufumi, Kenmotsu, Hirotsugu, Iwasawa, Tae, Misumi, Toshihiro, Yamanaka, Takeharu, Okamoto, Hiroaki
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: SAGE Publications 2020
विषय:
Study Protocol
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7238300/
https://ncbi.nlm.nih.gov/pubmed/32489433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920923431
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन